Overview of Dr. Nauseef
Dr. Jones Nauseef is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 7 years. He is one of 379 doctors at New York-Presbyterian Hospital and one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 10 publications and over 450 citings.
Office
505 E 70th St
New York, NY 10021Fax+1 212-746-4610
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2015
Certifications & Licensure
NY State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsSalivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.Miguel Muniz, Charles L Loprinzi, Jacob J Orme, Regina M Koch, Ahmed M Mahmoud
Cancer Treatment Reviews. 2024-06-01 - 15 citationsEmerging Prostate-specific Membrane Antigen-based Therapeutics: Small Molecules, Antibodies, and BeyondJones T. Nauseef, Neil H. Bander, Scott T. Tagawa
European Urology Focus. 2021-02-26 - 98 citationsPlatinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene AlterationsJose Mauricio Mota, Ethan Barnett, Jones T. Nauseef, Bastien Nguyen, Konrad H. Stopsack
JCO Precision Oncology. 2020-04-16
Press Mentions
Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate CancerApril 18th, 2023- ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate CancerFebruary 12th, 2021
- ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate CancerFebruary 11th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
